Report Categories
View AllRecent Articles
View All
CLX Clorox delivers Q1 2026 EPS above analyst forecasts stock rises 176 percent on positive investor reception
SCCF Sachem Q4 2025 earnings per share vastly exceed analyst estimates as stock holds steady
SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss
The competitive moat visible in Nelnet NNI earnings Nelnet posts 54 EPS miss against analyst estimates